Unknown

Dataset Information

Involvement of classic and alternative non-homologous end joining pathways in hematologic malignancies: targeting strategies for treatment.


ABSTRACT: Chromosomal translocations are the main etiological factor of hematologic malignancies. These translocations are generally the consequence of aberrant DNA double-strand break (DSB) repair. DSBs arise either exogenously or endogenously in cells and are repaired by major pathways, including non-homologous end-joining (NHEJ), homologous recombination (HR), and other minor pathways such as alternative end-joining (A-EJ). Therefore, defective NHEJ, HR, or A-EJ pathways force hematopoietic cells toward tumorigenesis. As some components of these repair pathways are overactivated in various tumor entities, targeting these pathways in cancer cells can sensitize them, especially resistant clones, to radiation or chemotherapy agents. However, targeted therapy-based studies are currently underway in t

SUBMITTER: Valikhani M 

PROVIDER: S-EPMC8564991 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature